Medtech 100 - EU Outlook 2023: Will The Road Ahead Be Any Smoother For The EU’s Medtech Regulations?

 
• By Amanda Maxwell
  
Generate a summary of this article
Listen to this article
Beta

Originally intended to increase medical device safety, the implementation of the EU’s medtech regulation was so hampered in 2022 that it had started to look as if the new regulations were a bigger potential threat to patients than any of the scandals leading to its more stringent requirements. With the European Commission’s latest plans to ease challenges around implementation, will 2023 be a more positive year for the EU medtech sector?

Bumpy Road Ahead
• Source: Shutterstock

During 2022, there had been little that had been straightforward when it came to the implementation of the EU’s new Medical Device and IVD Regulations. Originally due to first apply in 2020 and 2022 respectively, the slow rate of preparedness of the system and of its players resulted in warnings about products having to be unnecessarily withdrawn from the EU market and continuous calls to extend deadlines throughout the year.

As 2022 was drawing to a close, the volume of noise from the industry, notified bodies and even national regulatory...

Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

SpotifyApple PodcastsWebsite

More from MTI 100 Company Rankings

MTI 100 Feature: Manufacturing Devices In The Rollercoaster UK Market

 
• By Ashley Yeo

A scale-up strategy is the missing link in the UK devices industry, claims business research organization CPI. Own brand and contract medical manufacturer and packaging company Pennine Healthcare, and longstanding medical device CDMO Renfrew Group International, give their take on the environment for manufacturers and the opportunities for strengthening the industry base.

MTI 100: Macro Challenges Make Demands Of Newly Resilient Medtechs

 
• By Ashley Yeo

Global medtechs had a big enough challenge with COVID-19 and its aftermath before the full-scale regional conflict in Ukraine added more uncertainty to the question of when market normality would return.

MTI 100: Global Medtech Recovers Core Growth After A Year Like No Other

 
• By Ashley Yeo

With many medtechs restructuring for core growth in the post-pandemic era, Abbott relied on organic growth in 2022 to move to the top of the global medtech ranking. The strength of the US dollar was not kind to companies reporting in local currencies on converting revenues to dollars.

MTI 100 Outlook 2024: Shaping An Environment Where Technology Leads The Way

 
• By Ashley Yeo

Compliance with greenhouse gas reduction targets is not optional for medtech businesses who, besides the bigger picture, have their own sustainability to think of. Environmental demands, the evolution of care models, new delivery technologies and AI tools are influencing how medtechs must approach innovation. In the EU, the MDR is also having an effect on innovation strategies.

More from Market Intelligence

US De Novo Classifications

Devices granted De Novo marketing authorization by the US FDA. Data derived from FDA.gov Updated weekly.

US PMA Supplements

PMA supplements approved by US FDA’s Center for Devices and Radiological Health. Data derived from FDA.gov. Updated weekly.

Mergers and Acquisitions

Mergers and acquisitions in the medical device, diagnostics and digital health sectors. Data derived from Citeline’s Meddevicetracker.